Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 2h-1,4-benzoxazine-2-propanoic Acid, 6-(3-(difluoromethoxy)-5-fluorophenyl)-3,4-dihydro-alpha,alpha-dimethyl-4-((3-(trifluoromethyl)phenyl)sulfonyl)-, (2s)-
2. 3-((2s)-6-(3-(difluoromethoxy)-5-fluorophenyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2h-1,4-benzoxazin-2-yl)-2,2-dimethylpropanoic Acid
3. Lyc-55716
1. 2055536-64-4
2. Lyc-55716
3. Cintirorgon [inn]
4. Lpn433p0ea
5. 3-[(2s)-6-[3-(difluoromethoxy)-5-fluorophenyl]-4-[3-(trifluoromethyl)phenyl]sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]-2,2-dimethylpropanoic Acid
6. Chembl4472508
7. Lyc55716
8. Unii-lpn433p0ea
9. Cintirorgon [who-dd]
10. Cintirorgon (lyc-55716)
11. Schembl18302870
12. Gtpl10045
13. Bcp28882
14. Ex-a2635
15. Bdbm50515653
16. Nsc803601
17. S8860
18. Cs-7496
19. Nsc-803601
20. Lyc-55716lyc-55716
21. Ac-36326
22. Compound 32j [wo2016201225a1]
23. Hy-104037
24. A16863
25. F78355
26. Lyc 55716;lyc55716; Lyc-55716
27. (s)-3-(6-(3-(difluoromethoxy)-5-fluorophenyl)-4-(3-(trifluoromethyl)phenylsulfonyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-2-yl)-2,2-dimethylpropanoic Acid
28. 2h-1,4-benzoxazine-2-propanoic Acid, 6-(3-(difluoromethoxy)-5-fluorophenyl)-3,4-dihydro-alpha,alpha-dimethyl-4-((3-(trifluoromethyl)phenyl)sulfonyl)-, (2s)-
29. 3-((2s)-6-(3-(difluoromethoxy)-5-fluorophenyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2h-1,4-benzoxazin-2-yl)-2,2-dimethylpropanoic Acid
| Molecular Weight | 603.5 g/mol |
|---|---|
| Molecular Formula | C27H23F6NO6S |
| XLogP3 | 6.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 8 |
| Exact Mass | 603.11502760 g/mol |
| Monoisotopic Mass | 603.11502760 g/mol |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 1020 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
65
PharmaCompass offers a list of LYC-55716 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LYC-55716 manufacturer or LYC-55716 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LYC-55716 manufacturer or LYC-55716 supplier.
PharmaCompass also assists you with knowing the LYC-55716 API Price utilized in the formulation of products. LYC-55716 API Price is not always fixed or binding as the LYC-55716 Price is obtained through a variety of data sources. The LYC-55716 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LYC-55716 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LYC-55716, including repackagers and relabelers. The FDA regulates LYC-55716 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LYC-55716 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LYC-55716 supplier is an individual or a company that provides LYC-55716 active pharmaceutical ingredient (API) or LYC-55716 finished formulations upon request. The LYC-55716 suppliers may include LYC-55716 API manufacturers, exporters, distributors and traders.
LYC-55716 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LYC-55716 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LYC-55716 GMP manufacturer or LYC-55716 GMP API supplier for your needs.
A LYC-55716 CoA (Certificate of Analysis) is a formal document that attests to LYC-55716's compliance with LYC-55716 specifications and serves as a tool for batch-level quality control.
LYC-55716 CoA mostly includes findings from lab analyses of a specific batch. For each LYC-55716 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LYC-55716 may be tested according to a variety of international standards, such as European Pharmacopoeia (LYC-55716 EP), LYC-55716 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LYC-55716 USP).